These data indicate that PIM1 and PIM2 transcript and/or protein expression are increased in more aggressive CLL, prompting further questions about the mechanisms of their induction and consequences of their activity for the disease biology. Here, PIM2 is linked to B-cell chronic lymphocytic leukemia.